000 | 01763 a2200529 4500 | ||
---|---|---|---|
005 | 20250514062055.0 | ||
264 | 0 | _c20030509 | |
008 | 200305s 0 0 eng d | ||
022 | _a1343-1420 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkamoto, Masato | |
245 | 0 | 0 |
_aToll-like receptor signaling in anti-cancer immunity. _h[electronic resource] |
260 |
_bThe journal of medical investigation : JMI _cFeb 2003 |
||
300 |
_a9-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Surface _xphysiology |
650 | 0 | 4 |
_aCpG Islands _ximmunology |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 |
_aDNA-Binding Proteins _xdeficiency |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 | _aDrosophila Proteins |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 | _aLymphocyte Antigen 96 |
650 | 0 | 4 |
_aMembrane Glycoproteins _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aModels, Immunological |
650 | 0 | 4 |
_aMouth Neoplasms _xtherapy |
650 | 0 | 4 |
_aMycobacterium bovis _ximmunology |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aNeoplasms, Experimental _xtherapy |
650 | 0 | 4 |
_aPicibanil _xpharmacology |
650 | 0 | 4 |
_aReceptors, Cell Surface _xdeficiency |
650 | 0 | 4 |
_aTh1 Cells _xdrug effects |
650 | 0 | 4 | _aToll-Like Receptor 2 |
650 | 0 | 4 | _aToll-Like Receptor 4 |
650 | 0 | 4 | _aToll-Like Receptor 6 |
650 | 0 | 4 | _aToll-Like Receptor 9 |
650 | 0 | 4 | _aToll-Like Receptors |
700 | 1 | _aSato, Mitsunobu | |
773 | 0 |
_tThe journal of medical investigation : JMI _gvol. 50 _gno. 1-2 _gp. 9-24 |
|
999 |
_c12425481 _d12425481 |